Both sides have signed this (Bill Ranking)
H.R. 2319 · 119th Congress (2025-2026)
3 members · Left 1 · Center 1 · Right 1 (Bill Ranking)
| Sponsor | Rep. Boyle, Brendan F. (D-PA) (Introduced 03/25/2025) |
|---|---|
| Sponsor Voting Record | Lean left · DW-NOMINATE -0.38 · measured from every roll-call vote this member has cast (voteview.com) (Sponsor Ranking) |
| Support |
LLLCLRR support across the spectrum: 3 members signed on (Bill Ranking) this bill: sponsor + current cosponsors, each once |
| Committees | House - Energy and Commerce Committee; House - Energy and Commerce Committee; House - Energy and Commerce Committee |
| Latest Action | 04/22/2026 Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380. |
| Roll Call Votes | There have been no roll call votes |
| Source | view on congress.gov → |
Reported to House (11/18/2025)
Women and Lung Cancer Research and Preventive Services Act of 2025
This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.
The review must
119 HR 2319 EH: Women and Lung Cancer Research and Preventive Services Act of 2025 U.S. House of Representatives text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IB 119th CONGRESS2d Session H. R. 2319
IN THE HOUSE OF REPRESENTATIVES AN ACT To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.
1.Short titleThis Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2025.
2.Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a)In generalThe Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to— (1)research on lung cancer in women; (2)research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3)access to lung cancer preventive services; and (4)strategic public awareness and education campaigns on lung cancer. (b)ContentThe review and recommendations under subsection (a) shall include— (1)a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2)opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A)encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B)evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C)foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3)opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4)opportunities regarding the development of a national public education and awareness campaign on— (A)lung cancer in women and underserved populations; and (B)the importance of early detection of lung cancer. (c)ReportNot later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a). Passed the House of Representatives April 21, 2026.Kevin F. McCumber,Clerk.
119 HR 2319 IH: Women and Lung Cancer Research and Preventive Services Act of 2025 U.S. House of Representatives 2025-03-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I119th CONGRESS1st SessionH. R. 2319IN THE HOUSE OF REPRESENTATIVESMarch 25, 2025Mr. Boyle of Pennsylvania introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.1.Short titleThis Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2025.2.Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns(a)In generalThe Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to—(1)research on lung cancer in women;(2)research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;(3)access to lung cancer preventive services; and(4)strategic public awareness and education campaigns on lung cancer.(b)ContentThe review and recommendations under subsection (a) shall include—(1)a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;(2)opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—(A)encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;(B)evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and(C)foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;(3)opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and(4)opportunities regarding the development of a national public education and awareness campaign on—(A)lung cancer in women and underserved populations; and(B)the importance of early detection of lung cancer.(c)ReportNot later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).
119 HR 2319 PCS: Women and Lung Cancer Research and Preventive Services Act of 2025 U.S. House of Representatives 2026-04-22 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IICalendar No. 380119th CONGRESS2d SessionH. R. 2319IN THE SENATE OF THE UNITED STATESApril 22, 2026Received; read twice and placed on the calendarAN ACTTo direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.1.Short titleThis Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2025.2.Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns(a)In generalThe Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to—(1)research on lung cancer in women;(2)research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;(3)access to lung cancer preventive services; and(4)strategic public awareness and education campaigns on lung cancer.(b)ContentThe review and recommendations under subsection (a) shall include—(1)a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;(2)opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—(A)encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;(B)evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and(C)foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;(3)opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and(4)opportunities regarding the development of a national public education and awareness campaign on—(A)lung cancer in women and underserved populations; and(B)the importance of early detection of lung cancer.(c)ReportNot later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).Passed the House of Representatives April 21, 2026.Kevin F. McCumber,Clerk.April 22, 2026Received; read twice and placed on the calendar
119 HR 2319 RH: Women and Lung Cancer Research and Preventive Services Act of 2025 U.S. House of Representatives 2025-11-18 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IBUnion Calendar No. 332119th CONGRESS1st SessionH. R. 2319[Report No. 119–382]IN THE HOUSE OF REPRESENTATIVESMarch 25, 2025Mr. Boyle of Pennsylvania introduced the following bill; which was referred to the Committee on Energy and CommerceNovember 18, 2025Additional sponsors: Mr. Fitzpatrick and Mr. CiscomaniNovember 18, 2025Committed to the Committee of the Whole House on the State of the Union and ordered to be printedA BILLTo direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.1.Short titleThis Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2025.2.Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns(a)In generalThe Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to—(1)research on lung cancer in women;(2)research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;(3)access to lung cancer preventive services; and(4)strategic public awareness and education campaigns on lung cancer.(b)ContentThe review and recommendations under subsection (a) shall include—(1)a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;(2)opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—(A)encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;(B)evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and(C)foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;(3)opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and(4)opportunities regarding the development of a national public education and awareness campaign on—(A)lung cancer in women and underserved populations; and(B)the importance of early detection of lung cancer.(c)ReportNot later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).November 18, 2025Committed to the Committee of the Whole House on the State of the Union and ordered to be printed
The bill's own words, from our database (synced from the GPO BILLS XML); paragraph breaks added at the bill's section boundaries, nothing else changed.
| Date | Chamber | All Actions |
|---|---|---|
| 03/25/2025 | Library of Congress | Introduced in House |
| 03/25/2025 | Library of Congress | Introduced in House |
| 03/25/2025 | House floor actions | Referred to the House Committee on Energy and Commerce. |
| 04/29/2025 | House committee actions | Committee Consideration and Mark-up Session Held |
| 04/29/2025 | House committee actions | Ordered to be Reported by Voice Vote. |
| 11/18/2025 | Library of Congress | Reported by the Committee on Energy and Commerce. H. Rept. 119-382. |
| 11/18/2025 | House floor actions | Reported by the Committee on Energy and Commerce. H. Rept. 119-382. |
| 11/18/2025 | House floor actions | Placed on the Union Calendar, Calendar No. 332. |
| 04/21/2026 | House floor actions | Mrs. Harshbarger moved to suspend the rules and pass the bill. |
| 04/21/2026 | House floor actions | Considered under suspension of the rules. (consideration: CR H3020-3021) |
| 04/21/2026 | House floor actions | DEBATE - The House proceeded with forty minutes of debate on H.R. 2319. |
| 04/21/2026 | Library of Congress | Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020) |
| 04/21/2026 | House floor actions | On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020) |
| 04/21/2026 | House floor actions | Motion to reconsider laid on the table Agreed to without objection. |
| 04/22/2026 | Senate | Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380. |
| Title Type | Title |
|---|---|
| Display Title | Women and Lung Cancer Research and Preventive Services Act of 2025 |
| Short Title(s) from PCS (Placed on Senate Calendar) bill text | Women and Lung Cancer Research and Preventive Services Act of 2025 |
| Short Title(s) as Passed House | Women and Lung Cancer Research and Preventive Services Act of 2025 |
| Official Titles from EH (Engrossed in House) bill text | To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes. |
| Short Title(s) as Reported to House | Women and Lung Cancer Research and Preventive Services Act of 2025 |
| Short Title(s) as Introduced | Women and Lung Cancer Research and Preventive Services Act of 2025 |
| Official Title as Introduced | To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes. |
There are no amendments to this bill.
* = Original cosponsor
| Committee | Activity |
|---|---|
| House - Energy and Commerce Committee | 11/19/2025 Reported By |
| House - Energy and Commerce Committee | 04/29/2025 Markup By |
| House - Energy and Commerce Committee | 03/25/2025 Referred To |
Policy Area: Health
All data on this page comes from our own database (legislation.congress_* tables), synced daily from the GPO govinfo BILLSTATUS and BILLS collections. Formatted after congress.gov; nothing is generated. Member placement is their DW-NOMINATE score (voteview.com, Lewis et al.) - a measurement of roll-call voting behavior, not our judgement. Buckets: Left below −0.50 · Lean Left to −0.25 · Center to +0.25 · Lean Right to +0.50 · Right above +0.50. The bill's Support meter aggregates the people who signed the bill - sponsor and current cosponsors, each counted once - nothing else.